title: Response to letters regarding article, “statins and the risk of cancer after heart transplantation”.
authors.forename: Georg Marcus
authors.initials: GM
authors.lastname: Fröhlich
authors.forename: Frank
authors.initials: F
authors.lastname: Enseleit
authors.forename: Mathias
authors.initials: M
authors.lastname: Wolfrum
authors.forename: Michelle
authors.initials: M
authors.lastname: von Babo
authors.forename: Michelle
authors.initials: M
authors.lastname: Frank
authors.forename: Reto
authors.initials: R
authors.lastname: Berli
authors.forename: Mathias
authors.initials: M
authors.lastname: Hermann
authors.forename: Johannes
authors.initials: J
authors.lastname: Holzmeister
authors.forename: Georg
authors.initials: G
authors.lastname: Noll
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Lüscher
authors.forename: Frank
authors.initials: F
authors.lastname: Ruschitzka
authors.forename: Kaspar
authors.initials: K
authors.lastname: Rufibach
authors.forename: Markus
authors.initials: M
authors.lastname: Wilhelm
authors.forename: Volkmar
authors.initials: V
authors.lastname: Falk
mesh_terms: D005260:Female; D016027:Heart Transplantation; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D009369:Neoplasms / Q000453:epidemiology*; D011183:Postoperative Complications / Q000453:epidemiology*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors